Celularity (CELUW) Projected to Post Earnings on Thursday

Celularity (NASDAQ:CELUW) is projected to release its results before the market opens on Thursday, March 26th. Analysts expect Celularity to post earnings of ($1.50) per share for the quarter.

Celularity Stock Performance

NASDAQ:CELUW opened at $0.01 on Thursday. The stock’s 50 day moving average price is $0.01 and its 200 day moving average price is $0.02. Celularity has a 52-week low of $0.01 and a 52-week high of $0.10.

Celularity Company Profile

Celularity, Inc is a clinical-stage biotechnology company headquartered in Florham Park, New Jersey, that specializes in the development and commercialization of allogeneic “off-the-shelf” cell therapies derived from postpartum placental cells. Leveraging a proprietary platform of placental- and umbilical-derived cells, the company seeks to deliver immune-modulatory, regenerative and anti-inflammatory treatments across oncology, immunology and other therapeutic areas. By harnessing the natural properties of placental cells, Celularity aims to overcome the limitations of autologous therapies and scale production to serve a broad patient population.

The company’s pipeline includes CYNK-001, an investigational natural killer (NK) cell therapy being evaluated for hematological malignancies and solid tumors, as well as other cell-based programs targeting viral infections and tissue repair.